Noziplastischer Schmerz (2): Cui bono et quo vadis?

Walter Magerl

doi:10.1055/s-0045-1809856

VPT Magazin, Table of Contents

VPT Magazin 2025; 11(03): 26-30
DOI: 10.1055/s-0045-1809856

Wissen

Noziplastischer Schmerz (2): Cui bono et quo vadis?

Walter Magerl

Privatdozent für Physiologie, durch die „Deutsche Physiologische Gesellschaft“ (DPG) zertifizierter Fachphysiologe und Diplom-Psychologe; Stellvertretender Leiter des „Instituts für Neurophysiologie“ der Universität Heidelberg an der Medizinischen Fakultät Mannheim; Mitglied der „Deutschen Physiologischen Gesellschaft“ (DPG), der „International Association for the Study of Pain“ (IASP) und des „Deutschen Forschungsverbundes Neuropathischer Schmerz“ (DFNS); Leiter der Mannheimer Trainingseinheit des DFNS zur Ausbildung in „Quantitativ Sensorischer Testung“.

› Author Affiliations

Abstract

Zusammenfassung

Bedeutung der Klassifizierung für die Praxis und damit auch für die Patienten*innen – eine kritische Würdigung

Full Text

References

Literatur
1 Hoeijmakers JG, Faber CG, Lauria G. et al. Small-fibre neuropathies – advances in diagnosis, pathophysiology and management. Nat Rev Neurol 2012; 8: 369-379
2 Lauria G, Ziegler D, Malik R. et al. The role of sodium channels in painful diabetic and idiopathic neuropathy. Curr Diab Rep 2014; 14: 538
3 Marchi M, Salvi E, Andelic M. et al. TRPA1 rare variants in chronic neuropathic and nociplastic pain patients. Pain 2023; 164: 2048-2059
4 International Association for the Study of Pain (IASP). IASP Revises Its Definition of Pain for the First Time Since 1979. 2020 Accessed May 05, 2025 at: www.iasp-pain.org/wp-content/uploads/2022/04/revised-definition-flysheet_R2–1-1–1.pdf
5 Quintner J, Cohen M. The hijacking of “Nociplastic“. Painlosophy Blog. 2021 Accessed May 05, 2025 at: www.painlosophy.wordpress.com/2021/06/08/the-highjacking-of-nociplastic
6 Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet 2021; 397: 2082-2097
7 Bułdyś K, Górnicki T, Kałka D. et al. What Do We Know about Nociplastic Pain?. Healthcare (Basel) 2023; 11: 1794
8 Hausteiner-Wiehle C, Henningsen P. Nociplastic pain is functional pain. Lancet 2022; 399: 1603-1604
9 Cohen SP, Fitzcharles MA, Häuser W. Nociplastic pain is functional pain – Authors‘ reply. Lancet 2022; 399: 1604
10 Popkirov S, Enax-Krumova EK, Mainka T. et al. Functional pain disorders – more than nociplastic pain. NeuroRehabilitation 2020; 47: 343-353
11 World Health Organization (WHO). ICD-11 – International Classification of Diseases 11th Revision. 2019 Accessed May 05, 2025 at: https://www.icd.who.int/en
12 Cohen M, Quintner J, Weisman A. “Nociplastic Pain“: A Challenge to Nosology and to Nociception. J Pain 2023; 24: 2131-2139
13 Kosek E, Clauw D, Nijs J. et al. Chronic nociplastic pain affecting the musculoskeletal system: Clinical criteria and grading system. Pain 2021; 162: 2629-2634
14 Nijs J, Lahousse A, Kapreli E. et al. Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future. J Clin Med 2021; 10: 3203
15 European Medicines Agencies (EMA). Guideline on the clinical development of medicinal products intended for the treatment of pain – Scientific Guideline. 2017 Accessed May 05, 2025 at: www.ema.europa.eu/en/clinical-development-medicinal-products-intended-treatment-pain-scientific-guideline
16 Adler M, Taxer B. Quantitative sensorische Testung im Rahmen neuropathischer Schmerzen und ihre Bedeutung für die Physiotherapie. Schmerz 2022; 36: 437-446
17 Magerl W, Krumova EK, Baron R. et al. Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain 2010; 151: 598-605
18 Reimer M, Forstenpointner J, Hartmann A. et al. Sensory bedside testing: a simple stratification approach for sensory phenotyping. Pain Rep 2020; 5: e820
19 Nilges P, Rief W. F45.41 Chronische Schmerzstörung mit somatischen und psychischen Faktoren. Eine Kodierhilfe. Schmerz 2010; 24: 209-212
20 Barke A, Korwisi B, Nilges P. et al. Alles anders? Chronische Schmerzen sind in der ICD-11 keine psychische Störung mehr!. Psychotherapeutenjournal 2023; 22: 4-12
21 Aydede M, Shriver A. Recently introduced definition of „nociplastic pain“ by the International Association for the Study of Pain needs better formulation. Pain 2018; 159: 1176-1177
22 Kosek E, Clauw D, Nijs J. et al. Chronic nociplastic pain affecting the musculoskeletal system: Clinical criteria and grading system. Pain 2021; 162: 2629-2634
23 Fitzcharles MA, Cohen SP, Clauw DJ. et al. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021; 397: 2098-2110
24 Kosek E, Clauw D, Nijs J. et al. Chronic nociplastic pain affecting the musculoskeletal system: Clinical criteria and grading system. Pain 2021; 162: 2629-2634
25 Nijs J, Lahousse A, Kapreli E. et al. Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future. J Clin Med 2021; 10: 3203
26 Edwards RR, Almeida DM, Klick B. et al. Duration of sleep contributes to next-day pain report in the general population. Pain 2008; 137: 202-207
27 Kelleher E, Kaplan CM, Kheirabadi D. et al. The number of central nervous system-driven symptoms predicts subsequent chronic primary pain: evidence from UK Biobank. Br J Anaesth 2025; 134: 772-782
28 Neblett R, Cohen H, Choi Y. et al. The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain 2013; 14: 438-45
29 Neblett R, Hartzell MM, Cohen H. et al. Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample. Clin J Pain 2015; 31: 323-32
30 Adams GR, Gandhi W, Harrison R. et al. Do „central sensitization“ questionnaires reflect measures of nociceptive sensitization or psychological constructs? A systematic review and meta-analyses. Pain 2023; 164: 1222-1239
31 Ten Klooster PM, Simoes JP, Vonkeman HE. Limited content overlap between commonly used self-report instruments for central (pain) sensitization in rheumatology. Rheumatol Adv Pract 2024; 8: rkae108
32 Hodges PW, Sanchez R, Pritchard S. et al. Toward Validation of Clinical Measures to Discriminate Between Nociceptive, Neuropathic, and Nociplastic Pain: Cluster Analysis of a Cohort With Chronic Musculoskeletal Pain. Clin J Pain 2025; 41: e1281
33 Khillan A, Carter L, Amor DJ. et al. Methods to discriminate between nociceptive, neuropathic and nociplastic in children & adolescents: A systematic review of psychometric properties and feasibility. J Pain 2025; 6: 105388
34 Schmidt H, Drusko A, Renz MP. et al. Application of the grading system for “nociplastic pain“ in chronic primary and chronic secondary pain conditions: a field study. Pain 2025; 166: 196-211
35 Van den Broeke EN, Crombez G, Vlaeyen JWS. Reconceptualizing sensitization in pain: back to basics. Pain Rep 2024; 9: e1125
36 Treede RD, Rief W, Barke A. et al. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the International classification of diseases (ICD-11). Pain 2019; 160: 19-27
37 Kemp HI, Laycock H, Costello A. et al. Chronic pain in critical care survivors: a narrative review. Br J Anaesth 2019; 123: e372-e384
38 Chimenti RL, Hall MM, Dilger CP. et al. Local Anesthetic Injection Resolves Movement Pain, Motor Dysfunction, and Pain Catastrophizing in Individuals with Chronic Achilles Tendinopathy: A Nonrandomized Clinical Trial. J Orthop Sports Phys Ther 2020; 50: 334-343
39 Potter MN, Smitheman HP, Butera K. et al. Symptom Duration is not Related to Central Sensitization Inventory in Midportion Achilles Tendinopathy. Int J Sports Phys Ther 2025; 20: 696-705
40 Baroni A, Fregna G, Lamberti N. et al. Fatigue can influence the development of late-onset pain in post-COVID-19 syndrome: An observational study. Eur J Pain 2023; 28: 1-12
41 Foubert A, Roussel NA, Chantrain VA. et al. The Classification of Suspected Predominant Nociplastic Pain in People with Moderate and Severe Haemophilia: A Secondary Exploratory Study. Biomedicines 2023; 11: 2479
42 Telli H, Özdemir C. Is nociplastic pain, a new pain category, associated with biochemical, hematological, and inflammatory parameters. Curr Med Res Opin 2024; 11: 1-13
43 Martínez-Lavín M. Centralized nociplastic pain causing fibromyalgia: an emperor with no cloths?. Clin Rheumatol 2022; 41: 3915-3917
44 Xie Y, Thomas L, Barbero M. et al. Heightened pain facilitation rather than impaired pain inhibition distinguishes those with moderate/severe disability in work-related neck pain. Pain 2021; 162: 2225-2236
45 Elgueta-Cancino E, Sheeran L, Salomoni S. et al. Characterisation of motor cortex organisation in patients with different presentations of persistent low back pain. Eur J Neurosci 2021; 54: 7989-8005
46 Larkin TE, Kaplan CM, Schrepf A. et al. Altered network architecture of functional brain communities in chronic nociplastic pain. Neuroimage 2021; 226: 117504
47 Sandström A, Ellerbrock I, Löfgren M. et al. Distinct aberrations in cerebral pain processing differentiating patients with fibromyalgia from patients with rheumatoid arthritis. Pain 2022; 163: 538-547
48 Alshelh Z, Brusaferri L, Saha A. et al. Neuro-immune signatures in chronic low back pain subtypes. Brain 2022; 145: 1098-1110
49 Kratz AL, Whibley D, Alschuler KN. et al. Characterizing chronic pain phenotypes in multiple sclerosis: a nationwide survey study. Pain 2021; 162: 1426-1433
50 Kuisell C, Ploutz-Snyder R, Williams DA. et al. Adolescents and Young Adults With Sickle Cell Disease: Nociplastic Pain and Pain Catastrophizing as Predictors of Pain Interference and Opioid Consumption. Clin J Pain 2023; 39: 326-333
51 Scott JR, Williams DA, Harte SE. et al. Relationship Between Nociplastic Pain Involvement and Medication Use, Symptom Relief, and Adverse Effects Among People Using Medical Cannabis for Chronic Pain. Clin J Pain 2024; 40: 1-9
52 Kohns DJ, Scott R, Castellanos J. et al. The impact of nociplastic pain features on the response to physical therapy in patients with primary myofascial pain. J Back Musculoskelet Rehabil 2022; 35: 1143-1151
53 Joyce E, Carr G, Wang S. et al. Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patients. Breast Cancer Res Treat 2023; 197: 397-404
54 Ocay DD, Ross BD, Moscaritolo L. et al. The Psychosocial Characteristics and Somatosensory Function of Children and Adolescents Who Meet the Criteria for Chronic Nociplastic Pain. J Pain Res 2023; 16: 487-500
55 Kosek E. The concept of nociplastic pain – where to from here?. Pain 2024; 165: S50-S57
56 Ferro Moura Franco K, Lenoir D. et al. Prescription of exercises for the treatment of chronic pain along the continuum of nociplastic pain: A systematic review with meta-analysis. Eur J Pain 2021; 25: 51-70
57 Shraim MA, Massé-Alarie H, Hall LM. et al. Systematic Review and Synthesis of Mechanism-based Classification Systems for Pain Experienced in the Musculoskeletal System. Clin J Pain 2020; 36: 793-812

Quelle
Magerl W. Update: Noziplastischer Schmerz. MSK – Muskuloskelettale Physiotherapie 2024; 28: 101-110